These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 16879206

  • 21. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review.
    Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN.
    Ann Intern Med; 2004 Jan 20; 140(2):112-20. PubMed ID: 14734334
    [Abstract] [Full Text] [Related]

  • 22. Management of adult idiopathic thrombocytopenic purpura.
    Cines DB, McMillan R.
    Annu Rev Med; 2005 Jan 20; 56():425-42. PubMed ID: 15660520
    [Abstract] [Full Text] [Related]

  • 23. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.
    Godeau B, Porcher R, Fain O, Lefrère F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, Bourgeois E, Haiat S, Varet B, Leporrier M, Papo T, Khellaf M, Michel M, Bierling P.
    Blood; 2008 Aug 15; 112(4):999-1004. PubMed ID: 18463354
    [Abstract] [Full Text] [Related]

  • 24. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct 15; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 25. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
    Rashid RM, Nabi Z, Ansari AZ, Qaiser QA.
    BMC Nephrol; 2018 Mar 20; 19(1):69. PubMed ID: 29554892
    [Abstract] [Full Text] [Related]

  • 26. Canine idiopathic thrombocytopenic purpura.
    Lewis DC, Meyers KM.
    J Vet Intern Med; 1996 Mar 20; 10(4):207-18. PubMed ID: 8819045
    [Abstract] [Full Text] [Related]

  • 27. Positioning new treatments in the management of immune thrombocytopenia.
    Arnold DM.
    Pediatr Blood Cancer; 2013 Mar 20; 60 Suppl 1(Suppl 1):S19-22. PubMed ID: 23109488
    [Abstract] [Full Text] [Related]

  • 28. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C, Liu HF, Chen XH, Gao L, Gao L, Liu Y, Kong PY, Sun AH, Zhang X.
    Clin Ther; 2014 Mar 01; 36(3):385-8. PubMed ID: 24594069
    [Abstract] [Full Text] [Related]

  • 29. [New treatment methods for autoimmune thrombocytopenia].
    Koene HR.
    Ned Tijdschr Geneeskd; 2007 Nov 24; 151(47):2609-14. PubMed ID: 18161261
    [Abstract] [Full Text] [Related]

  • 30. Autoimmune thrombocytopenia.
    Chong BH, Ho SJ.
    J Thromb Haemost; 2005 Aug 24; 3(8):1763-72. PubMed ID: 16102043
    [Abstract] [Full Text] [Related]

  • 31. Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia.
    Tamary H, Roganovic J, Chitlur M, Nugent DJ.
    Ann Hematol; 2010 Jul 24; 89 Suppl 1(Suppl 1):5-10. PubMed ID: 20358200
    [Abstract] [Full Text] [Related]

  • 32. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D.
    Hematology; 2012 Apr 24; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [Abstract] [Full Text] [Related]

  • 33. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
    Todorović-Tirnanić M, Obradović V, Rolović Z, Suvajdzić N, Elezović I, Colović M, Pavlović S, Bosnjaković V.
    Glas Srp Akad Nauka Med; 2005 Apr 24; (48):119-35. PubMed ID: 16405235
    [Abstract] [Full Text] [Related]

  • 34. How we treat primary immune thrombocytopenia in adults.
    Liu XG, Hou Y, Hou M.
    J Hematol Oncol; 2023 Jan 19; 16(1):4. PubMed ID: 36658588
    [Abstract] [Full Text] [Related]

  • 35. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
    Peñalver FJ, Jiménez-Yuste V, Almagro M, Alvarez-Larrán A, Rodríguez L, Casado M, Gallur L, Giraldo P, Hernández R, Menor D, Rodríguez MJ, Caballero D, González R, Mayans J, Millán I, Cabrera JR, Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP.
    Ann Hematol; 2006 Jun 19; 85(6):400-6. PubMed ID: 16550390
    [Abstract] [Full Text] [Related]

  • 36. Immune thrombocytopenia: no longer 'idiopathic'.
    McCrae K.
    Cleve Clin J Med; 2011 Jun 19; 78(6):358-73. PubMed ID: 21632906
    [Abstract] [Full Text] [Related]

  • 37. [Current treatment of primary immune thrombocytopenia].
    Lozano ML, Vicente V.
    Med Clin (Barc); 2014 May 06; 142(9):399-405. PubMed ID: 23809409
    [Abstract] [Full Text] [Related]

  • 38. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
    Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S.
    Thromb Haemost; 2008 Jan 06; 99(1):4-13. PubMed ID: 18217129
    [Abstract] [Full Text] [Related]

  • 39. Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment.
    Rossi G, Cattaneo C, Motta M, Pizzocaro C, Lanzi S, Pouchè A.
    Hematol J; 2002 Jan 06; 3(3):148-52. PubMed ID: 12111651
    [Abstract] [Full Text] [Related]

  • 40. [Treatment of idiopathic thrombocytopenic purpura in adults].
    Godeau B, Bierling P.
    Presse Med; 2008 Sep 06; 37(9):1292-8. PubMed ID: 18644317
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.